INO

Inovio Pharmaceuticals, Inc.

A maker of DNA-based vaccines and medicines that teach the body's own cells to fight disease. The company designs synthetic DNA instructions and delivers them with its hand-held CELLECTRA device, whose brief electrical pulses open tiny pores in cells to target cancers and HPV-related conditions. Founded in 1983 as Biotechnologies & Experimental Research, it later operated as Genetronics and took its current name after acquiring the Norwegian gene-delivery firm Inovio in 2005.

Recent Activity

Show $

2020Q4

2 sells

ARK Genomic Revolution ETFEXIT

-902.5K shares

ARK Genomic Revolution ETFEXIT

-902.5K shares

Maverick CapitalEXIT

-38.1K shares

Maverick CapitalEXIT

-38.1K shares

2020Q3

1 buy2 sells

ARK Genomic Revolution ETFTRIM

-157.3K shares(-14.8%)

ARK Genomic Revolution ETFTRIM

-157.3K shares(-14.8%)

ARK InvestEXIT

-771.4K shares

ARK InvestEXIT

-771.4K shares

Maverick CapitalADD

+19.2K shares(+101.2%)

Maverick CapitalADD

+19.2K shares(+101.2%)

2020Q2

2 buys1 sell

ARK Genomic Revolution ETFNEW

+1.06M shares

ARK Genomic Revolution ETFNEW

+1.06M shares

ARK InvestTRIM

-866.5K shares(-52.9%)

ARK InvestTRIM

-866.5K shares(-52.9%)

Maverick CapitalNEW

+18.9K shares

Maverick CapitalNEW

+18.9K shares

2020Q1

1 sell

ARK InvestTRIM

-2.95M shares(-64.3%)

ARK InvestTRIM

-2.95M shares(-64.3%)

Loading more activity...